There is growing interest in using PSMA-based imaging in gross target volume delineation for radiation therapy planning since molecular imaging enables the delineation of the biologically active tumor—based on increased PSMA expression on specific information—essential for effective treatment. Here, FOLH1 is linked to neoplasm.